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Abstract
Background: Gut barrier loss has been implicated as a critical event in the occurrence of postoperative complications. We
aimed to study the development of gut barrier loss in patients undergoing major non-abdominal surgery.
Methodology/Principal Findings: Twenty consecutive children undergoing spinal fusion surgery were included. This kind
of surgery is characterized by long operation time, significant blood loss, prolonged systemic hypotension, without directly
leading to compromise of the intestines by intestinal manipulation or use of extracorporeal circulation. Blood was collected
preoperatively, every two hours during surgery and 2, 4, 15 and 24 hours postoperatively. Gut mucosal barrier was assessed
by plasma markers for enterocyte damage (I-FABP, I-BABP) and urinary presence of tight junction protein claudin-3.
Intestinal mucosal perfusion was measured by gastric tonometry (PrCO2,P r-aCO2-gap). Plasma concentration of I-FABP, I-
BABP and urinary expression of claudin-3 increased rapidly and significantly after the onset of surgery in most children.
Postoperatively, all markers decreased promptly towards baseline values together with normalisation of MAP. Plasma levels
of I-FABP, I-BABP were significantly negatively correlated with MAP at K hour before blood sampling (20.726 (p,0.001),
20.483 (P,0.001), respectively). Furthermore, circulating I-FABP correlated with gastric mucosal PrCO2,P r-aCO2-gap
measured at the same time points (0.553 (p=0.040), 0.585 (p=0.028), respectively).
Conclusions/Significance: This study shows the development of gut barrier loss in children undergoing major non-
abdominal surgery, which is related to preceding hypotension and mesenterial hypoperfusion. These data shed new light
on the potential role of peroperative circulatory perturbation and intestinal barrier loss.
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Introduction
Patients undergoing major surgery or sustaining severe trauma
are at risk of developing morbidity and mortality from postoper-
ative or posttraumatic systemic inflammatory response syndrome
(SIRS), sepsis and multiple organ failure (MOF). The development
of such potentially lethal complications in relatively healthy
surgical or trauma patients is poorly understood [1,2]. Moreover,
few human studies investigated the hypothesis, generated from
animal studies, that the intestines are central in the origin of
postoperative and posttraumatic sequelae [3–5]. Major surgery
accompanied by systemic hypotension and blood loss is thought to
lead to redistribution of blood to preserve the vital organs (brain
and heart) at the expense of the splanchnic circulation [3–5]. Low
mesenteric blood flow subsequently leads to injury of the cells at
the most distal point from the mucosal blood supply, being the
mature enterocytes [6].
Experimental animal models, resembling the clinical situation of
major surgery and trauma, show that haemorrhagic shock leads to
disruption of the gut barrier, measured by elevated circulating
levels of Fatty Acid Binding Proteins (FABP), originating from
damaged intestinal epithelial cells and derangement of tight-
junctions [7,8]. Moreover, translocation of macromolecules,
microbial products and microbiota from the intestinal lumen to
the circulation and mesenteric lymph nodes, spleen and liver occur
[5,7]. The inflammatory response to translocated microbial
products as endotoxin has been reported to be induced via
various innate immune mechanisms, ranging from Toll Like
Receptors to complement activation [9,10].
Studies in patients undergoing major gastro-intestinal, cardiac
or vascular surgery, investigating the role of the gut in the
development of postoperative complications, are largely restricted
to data on increased intestinal permeability for sugars,
51Cr-EDTA
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report changes in these parameters in patients following major
surgery, indicating that the gut barrier is injured [11–14].
However, other reports using these tests lack to support these
data [15–18]. Moreover, the value of measuring gut barrier with
the use of sugar absorption probes is argued [19]. In conclusion,
the debate regarding the involvement of the gut in patients
undergoing major surgery is still open.
Plasma and urinary markers are currently available as useful
non-invasive tools to study the condition of enterocytes and tight-
junctions (TJ), the two components comprising the gut mucosal
barrier. Enterocyte damage was assessed using plasma levels of
Intestinal-Fatty Acid Binding Protein (I-FABP), a small cytosolic,
water-soluble protein, primarily limited to mature enterocytes of
small and large intestine [20]. I-FABP plasma levels rise rapidly
after episodes of acute intestinal ischaemia and inflammation [20–
22]. Next, also circulating levels of Ileal-Bile Acid Binding Protein
(I-BABP), which is exclusively present in mature enterocytes of the
jejunum and ileum, were assessed [23]. TJ between neighbouring
enterocytes are an important constituent of the intestinal epithelial
barrier [24]. The transmembrane TJ protein Claudin-3, the
essential sealing protein, disappears rapidly from the TJ following
haemorrhagic shock and is released into the urine (own
unpublished data).
The principal aim of this study was to investigate whether major
non-abdominal surgery leads to intestinal barrier loss.
Methods
Study design and patients
This is a prospective clinical observational study in children
undergoing spinal fusion surgery because of scoliosis in the
University Hospital Maastricht between March 2006 and October
2007. Major spinal fusion surgery is characterized by long
operation time, significant blood loss, prolonged systemic hypo-
tension and the potential development of postoperative complica-
tions [25]. This type of surgery was chosen because it does not
directly compromise the intestines by intestinal manipulation or
the use of extracorporeal circulation [25].
Informed, written consent was obtained by all patients or both
parents/caretakers whose information was used in the study prior
to inclusion; the study was conducted with approval from the local
medical ethical committee.
Surgical procedures
Preoperative preparation and anaesthesia. Anaesthesia
was induced and maintained with either a volatile based technique
with sevoflurane or an intravenous technique with propofol,
combined with an opioid and a non-depolarising muscle relaxant.
Sensory evoked potentials were monitored in patients at risk for
spinal cord problems during surgery. According to the hospital
protocol an intravenous technique with propofol was used in these
patients. All patients were intubated and ventilator settings were
adjusted to obtain normocapnia. Each patient had a forced-air
warming system and all intravenous fluids were warmed to prevent
hypothermia.
In addition to standard monitoring an arterial line was inserted
into a radial artery to measure arterial pressure and to sample
arterial blood, and a catheter was introduced into the bladder to
measure urine output. Blood-soaked gauzes were weighted as they
were passed off the surgical field and the blood content of the cell
saver was measured to measure blood loss.
Perioperative fluid therapy was adapted to the individual patient
with the aim to keep the patient normovolaemic throughout the
operation. Isotonic crystalloids were used for maintenance and
third space losses. Blood loss was replaced 1:1 with blood or colloid
or 3:1 with crystalloids. Fluid administration was guided by
calculation of maintenance and third space losses, blood loss, the
arterial blood pressure, and haemoglobin values. There was no
protocol to keep the blood pressure above or below a certain value.
Surgery. All the operations were performed by 2 senior spine
surgeons (LvR and AvO) using three fusion approaches: posterior
spinal fusion (PSF), anterior spinal fusion (ASF), and combined
anterior and posterior fusion. The decision regarding the preferred
fusion was made based on curve location, aetiology, rigidity, and
the child’s age, according to the current standards of scoliosis
operative repair.
In PSF, the patient was positioned prone on padded chest rolls,
rolled blanket bolster, or a Wilson spinal frame to provide
adequate cushioning for the chest and abdomen while allowing
vacant space preventing abdominal pressure. The skin was incised
in a straight line over the vertebrae to be fused. Following
osteotomy of all the spinous processes and facets included at the
fusion area, the vertebrae were instrumented with combinations of
pedicle-screws and hooks (CD Horizon Legacy 5.5 or 4.5 spinal
systems, Medtronic, Heerlen, the Netherlands). Curve correction
was performed with a combination of derotation and compres-
sion–distraction manoeuvres, and, if necessary, also by in situ
bending of the rods. In ASF, the patient was placed on the
operating table in the lateral position. The approach is from the
convex scoliotic side. A thoracoabdominal approach, which
included a split of the diaphragm near its insertion, retroperitoneal
approach, or lateral intrathoracic approach was performed
through the side of the curve convexity, with the patient lying
on his side. Following exposure of the vertebrae, the involved discs
and ribs were excised and the segmental vessels ligated or
preserved. In all cases of combined fusion, single-staged proce-
dures were carried out.
CD Horizon Legacy 5.5 or 4.5 spinal systems were used
depending on age and weight of the patient. In case of anterior
instrumentation CD Horizon Eclipse spinal system was used
(Medtronic). No drains were used.
Postoperative care. At the end of the surgery, all the
children were transferred to the paediatric Intensive Care Unit
(ICU). Extubation was performed after stabilization of vital signs
and according to accepted weaning parameters (usually 4–6 hours
after surgery). Paediatric ICU management was provided by the
attending physicians guided by the same general management
strategy and consisted of intravenous fluid administration,
correction of hypovolaemia, electrolyte disturbances and/or
anaemia and analgesics (acetaminophen and morphine).
Antibiotic cover (amoxicillin with clavulanate) was given starting
preoperatively until 24 hours after the end of surgery. Oral feeding
was introduced the day after surgery.
Follow-up in the ICU included a daily physical examination,
vital signs monitoring, routine blood tests, and chest radiographs
or other ancillary tests as required. The attending physicians
recorded complications and events.
Blood and urine sampling
Blood samples were collected from the arterial line in pre-chilled
EDTA vacuum tubes (BD vacutainer, Becton Dickinson Diagnos-
tics, Aalst, Belgium) and kept on ice. Blood was centrifuged at 4uC,
40006G for 15 minutes. Plasma was immediately stored in
aliquots at 280uC until analysis. Blood was sampled before
surgery (after the induction of anaesthesia), at 2 hours intervals
during surgery and 2, 4, 15 and 24 hours postoperatively from the
arterial line.
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bladder catheter, kept on ice and then frozen at 280uC in aliquots
within 2 hours of collection. Urine was collected every 20 minutes
in the first 2 hours during surgery and thereafter at the same
moments as blood was sampled.
Measurements of FABP and claudin-3
Plasma concentrations of I-FABP were determined using a
highly specific commercially available enzyme-linked immunosor-
bent assay (ELISA) that selectively detects human I-FABP
(standard: 20–5,000 pg/ml), kindly provided by Hycult Biotech-
nology (Uden, the Netherlands) and I-BABP (standard: 0.32–
5 ng/ml) as previously described [26].
Claudin-3 urine levels were analyzed by western blotting.
Equal amounts of each sample (adjusted to urinary creatinine
levels) were separated by SDS-PAGE gel, transferred to PVDF-
membrane and probed using primary antibody to claudin-3
(Rabbit anti-claudin-3 (34–1700), Zymed Laboratories, San
Francisco, CA). After incubation with goat anti rabbit HRP-
conjugated secondary antibody (Jackson, West Grove, PA),
signal was detected by supersignal west pico chemiluminescence
substrate (Pierce, Etten-Leur, the Netherlands). Band intensity
was semi-quantitatively analyzed using Quantity One (Biorad,
Hercules, CA).
Measurements of gastric mucosal tonometry
A gastric tonometry catheter (14F, Datex Ohmeda, Helsinki,
Finland) was introduced for measurement of intramucosal carbon
dioxide pressure (PrCO2 in kPa) throughout the surgical procedure
in the last seven patients, using the gas-automated capnograph
(Tonocap TC-200, Datex-Ohmeda).
Gastric tonometry measurements (PrCO2, and mucosal-arterial
pCO2 gap (Pr-aCO2-gap)) were measured at 30-minute intervals
from the start until the end of surgery using gas-automated
capnography. The pCO2 values of the blood gases were corrected
for the central blood temperature measurements, using the
formulas provided by the manufacturer (ABL 100, Radiometer,
Copenhagen, Denmark).
Statistical analysis
Statistical analysis was performed with Prism 4.0 for Windows
(GraphPad Software Inc. San Diego, CA) and SPSS 15.0 (SPSS,
Inc., Chicago, IL). Plasma FABP concentrations were presented as
mean6standard error (SEM). Normality of all data obtained was
verified by Kolmogorov-Smirnov test.
Linear mixed model regression was used to analyze changes
over time in plasma FABP levels. Within-person correlations
between mean arterial pressure (MAP), PrCO2/CO2-gap and
circulating levels of FABP at all studied time points were
computed. Mixed model analysis accounts for unbalanced
numbers of samples measured, because at some time points not
all samples could be obtained because of removal of the arterial
line. Differences in plasma FABP levels between individual time
periods were compared using t tests of the mixed model procedure.
Next, to characterize the total amount of intestinal mucosal cell
injury during surgery, area under the curve (AUC) for I-FABP and
I-BABP was calculated for each patient. The AUCI-FABP and
AUCI-BABP for patients with and without early complications was
compared using unpaired t test. Early complications were defined
as complications occurring in the intraoperative or initial
hospitalization period.
A p-value below 0.05 was considered to be statistically
significant.
Results
Patients
Twenty patients undergoing spinal fusion surgery were
consecutively included in the study, 15 girls and 5 boys. Median
age was 12 years (range: 2–16 years). Demographic, surgical and
fluid balance data are presented in Table 1. Intraoperative fluid
resuscitation was adequate as evidenced by; 1) a mean (SEM)
positive fluid balance (total fluid in minus blood loss) of 13 (1) ml/
kg/hr; 2) adequate diuresis; 3) low plasma lactate levels and; 4)
adequate plasma haemoglobin value (data not shown).
Plasma I-FABP, I-BABP
The plasma concentration of I-FABP increased rapidly after the
initiation of surgery from a mean (SEM) baseline value of 221 (32)
pg/ml shortly before start of surgery, under anaesthesia (in-house
mean normal value: 106 pg/ml, range: 41-336 pg/ml) to 348 (44) pg/ml
at 2 hours after the onset of surgery (p=0.006) (Figure 1a).
Thereafter, the mean plasma levels increased further to 369 (33)
pg/ml (p,0.001) at 4 hours after initiation of surgery. The peak
value of 443 (69) pg/ml (p,0.001) was reached at 6 hours after
the start of surgery, which often represented the end of surgery.
Thirteen patients showed an increase in plasma I-FABP levels of at
least twofold during surgery; while 7 patients had relatively
unchanged circulating I-FABP values. Plasma concentrations of I-
FABP decreased towards baseline values from 2 hours after the
end of surgery onwards.
Similar to the I-FABP levels, mean I-BABP plasma concentra-
tions also increased significantly between 2 and 8 hours after start
of surgery compared to baseline values in most of the patients
(Figure 1b).
Since FABP are excreted by the kidneys, we evaluated whether
high plasma values of FABP could be caused by impaired renal
function. Diuresis during and after surgery was adequate (Table 1)
and plasma creatinine values were not elevated, which indicates
that elevation of plasma FABP was caused by enterocyte cell
death.
Urinary claudin-3
The urinary claudin-3:creatinine ratio immediately increased
during the first 20 minutes of surgery. In the next 2 hours, the
claudin-3:creatinine ratio remained high and thereafter a decrease
towards preoperative values was detected (Figure 2).
Gastric tonometry and mean arterial pressure in relation
to intestinal damage
The very short circulating half-life of FABP (approximately
11 minutes) [27] allows to relate the presence of enterocyte cell
damage with preceding systemic hypotension and gastric mucosal
hypoperfusion. To this end within-person correlations were
studied between circulating levels of I-FABP, I-BABP and
intraoperative MAP at K hour before the blood sample was
collected in which FABP concentration was measured, and
PrCO2,P r-aCO2-gap at the same moment of blood sampling.
Interestingly, plasma levels of I-FABP, I-BABP were significantly
negatively correlated with MAP at K hour before blood sampling
(correlation: 20.726 (p,0.001); 20.483 (P,0.001), respectively),
indicating a relationship between enterocyte cell damage and
preceding systemic hypotension (Figure 3, Table 2). Furthermore,
circulating values of I-FABP correlated with gastric mucosal
PrCO2 and Pr-aCO2-gap measured at the same time points
(correlation: 0.553 (p=0.040) and 0.585 (p=0.028), respectively),
whereas no correlation was observed between plasma levels of I-
BABP and PrCO2 or Pr-aCO2-gap. These data show a clear
Gut Damage during Surgery
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enterocyte cell death (I-FABP), hypotension and splanchnic
hypoperfusion, assessed by gastric mucosal PrCO2 and Pr-aCO2-gap.
Complications
Six patients had nine early complications, including postoper-
ative fever (n=3), urinary tract infection (n=2), pneumonia
(n=1), wound infection (n=1), peroperative anaphylactic reaction
to poly(O-2-hydroxyethyl)starch (Venofundin) (n=1) and melaena
of unknown origin (n=1).
The mean AUCI-FABP for the six patients with complications
was 222 pg*hr/ml (range: 0–493 pg*hr/ml), while for patients
without complications the mean AUCI-FABP was 81 pg*hr/ml
(range: 0–222 pg*hr/ml) (p=0.032) (Figure 4). No significant
changes were found in mean AUCI-BABP during surgery between
patients with and without complications (3.1 vs. 2.0 ng*hr/ml,
p=0.341).
Discussion
The data showing an early increase of circulating FABP and
urinary claudin-3, followed by rapid return towards baseline
values, indicate that the patients suffered transient injury to the
mature enterocytes and their tight junctions. Interestingly, similar
kinetics of circulating FABP and urinary claudin-3 were found in
all patients, regardless of extension of surgery or amount of blood
loss. It remains to be established whether this insult is sufficient for
a breakdown of the intestinal mucosal barrier, eliciting an
inflammatory response and postoperative complications, as has
been shown in animal studies [5,8,28]. Although this study was
only set up to explore the development of intestinal mucosal cell
damage during major non-abdominal surgery, a limited analysis of
the postoperative course of patients with intestinal mucosal cell
damage revealed that higher plasma levels of I-FABP were
associated with a higher rate of postoperative complications. All
possible complications are described as end point, because this
type of surgery in relatively healthy children rarely results in
important complications, including sepsis, MOF and death.
Nevertheless, the described complications were associated with
prolonged hospitalization. Taken together, this study did not prove
causality that the observed gut barrier loss and inflammation are
the inducing factors for SIRS and MOF. Additional work,
Figure 1. Time course of mean (SEM) plasma I-FABP (a) and I-
BABP (b) levels in children undergoing spinal fusion surgery
(n=20). *p ,0.05 vs. baseline values.
doi:10.1371/journal.pone.0003954.g001
Figure 2. Time course of urinary claudin-3:creatinine ratio of
two representative of the last five children undergoing spinal
fusion surgery.
doi:10.1371/journal.pone.0003954.g002
Figure 3. Translated values of plasma levels of circulating I-
FABP and translated values of preceding systemic hypotension
(MAP t-Khr) in children undergoing spinal fusion surgery were
plotted. Circulating I-FABP correlated significantly negatively with MAP
at K hour before blood sampling (n=89, correlation: 20.726
(p,0.001). Translations of both variables are specific for an individual
in such a way that all within-person means correspond to the zeros in
the plot. In this way the variation of individual levels are cancelled and
the pure association of both variables remains.
doi:10.1371/journal.pone.0003954.g003
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serious complications, is needed in order to fully unravel the
sequelae of the observed gut barrier loss.
Our work is supported by three previous studies showing the
temporary presence of intestinal villous cell damage, measured by
increased urinary levels of I-FABP, in patients undergoing cardiac
surgery with cardiopulmonary bypass (CPB) [29–31]. In line, the
patients with high urinary I-FABP levels developed postoperative
gastro-intestinal complications [29]. The use of CPB was shown to
be responsible for alterations in blood flow with consequently
intestinal mucosal hypoxia and villous tip ischemia [30,31]. In our
patients a similar influence of variation in blood flow on the
provocation of intestinal villous cell injury was found, without the
use of extracorporeal circulation.
Hypotension is often accepted to diminish blood loss and
thereby facilitating surgical exposure and reducing the need for
blood transfusions during e.g. oromaxillofacial, neurosurgery and
major orthopaedic surgery [32,33]. Peroperative hypotension is
considered to be caused by hypovolaemia and/or anaesthetics. It
is unlikely that the children undergoing spinal fusion repair were
hypovolaemic, because fluids were administered adequately,
which is reflected by positive fluid balance, low plasma lactate
levels and sufficient diuresis. Therefore, anaesthetics are the major
cause of low MAP. Propofol and sevoflurane, which were used in
almost all children as anaesthetic agents have only minimal effects
on cardiac output, but they decrease the systemic vascular
resistance significantly, resulting in hypotension [34]. However,
the fall in blood pressure together with prolonged surgery and
anaemia potentially results in tissue hypoxia, represented by
transient splanchnic hypoperfusion, impairment of hepatocellular
integrity, renal dysfunction and visual loss because of optic nerve
ischemia [32,33,35]. Our study shows for the first time the relation
between accepted hypotension and the development of intestinal
mucosal cellular damage in patients undergoing major non-
abdominal surgery.
The clinical consequences of our findings are challenging. It is
clear that major (non-abdominal) surgery, accompanied by
accepted systemic hypotension aimed at minimizing intraoperative
blood loss, can induce splanchnic mucosal hypoperfusion and gut
barrier loss. While organ blood flow regulation is preserved over a
wide range of MAP, organ perfusion becomes pressure dependent
when the MAP decreases below a certain critical level (autoreg-
ulatory threshold). The autoregulatory threshold varies between
different organs, the presence of diseases and age; little data are
available on the autoregulatory threshold in children, and no
studies report on the child intestinal autoregulation. We are
currently performing a study in which haemodynamic optimiza-
tion, aimed at normotension and flow-directed parameters, is
intended during major surgery in order to prevent the develop-
ment of intestinal damage.
The present study concerns relatively healthy children and
young adolescents, who have an insignificant risk for important
complications after major surgery. In line, studies with older
patients undergoing surgery or trauma show that increasing age is
one of the most crucial risk factors influencing adverse outcome
[36,37]. Therefore, we speculate that the loss of the intestinal
mucosal barrier as observed in our study in relatively healthy
children undergoing major non-abdominal surgery would have a
larger effect on the development of postoperative complications in
older patients. Collectively, these findings shed a new light on the
potential role of intestinal barrier compromise during major
surgery, which was adapted from numerous animal studies, but
now reported in relatively healthy children and adolescents
undergoing major non-abdominal surgery. Furthermore, we
consider that these results indicate a need to re-examine currently
accepted criteria of haemodynamic parameters in patients
undergoing major surgery.
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